Cited by 169Antifungal resistance and susceptibilityFungal Infections and StudiesYeasts and Rust Fungi Studies

Emerging and reemerging fungal infections

Open access
Lockhart, Shawn R., Guarner, Jeannette·2019·Seminars in Diagnostic Pathology

Abstract

Fungal infections throughout the world appear to be increasing. This may in part be due to the increase in the population of patients that are susceptible to otherwise rare fungal infections resulting from the use of immune modulating procedures such as hematopoietic stem cell transplants and drugs like tissue necrosis factor antagonists. Histoplasma capsulatum, an endemic fungus throughout North and South America, is reemerging among HIV+ patients in Central and South America and among patients taking tissue necrosis factor antagonists and other biologics in North America. Fusarium species, a relatively rare fungal infection, is reemerging worldwide in the immunocompromised populations, especially those who are neutropenic like hematopoietic stem cell transplant recipients. A new yeast species is currently emerging worldwide: Candida auris, unknown just a decade ago. It is causing large healthcare-associated outbreaks on four continents and is spreading throughout the world through patient travel. In this review the epidemiology, pathology, detection and treatment of these three emerging and reemerging fungi will be discussed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.semdp.2019.04.010

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lockhart, S. R., & Guarner, J.
Affiliations
  • Centers for Disease Control and Prevention (US)
  • Emory University (US)
Corresponding author
Lockhart, Shawn R.
Venue
Seminars in Diagnostic Pathology
Publisher
Elsevier BV
Published
2019-05
Volume
36
Issue
3
Pages
177-181
ISSN
0740-2570 (ISSN-L)
OpenAlex
W2935745971
Cited by
169
References
61
Citations by year
2026: 11 · 2025: 18 · 2024: 29 · 2023: 35 · 2022: 23 · 2021: 29 · 2020: 20 · 2019: 4
FWCI
2.66
Type
journal article
Language
en
Open access
Locations
  • Seminars in Diagnostic Pathology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institutes of Health (CC999999)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Yeasts and Rust Fungi Studies
Keywords
emerging fungal infections, Histoplasma capsulatum, Fusarium, Candida auris, HIV, hematopoietic stem cell transplantation, immunocompromised patients, neutropenia, healthcare-associated outbreaks, fungal epidemiology, fungal pathology, fungal detection, antifungal therapy
MeSH terms
Fungi, Humans, Mycoses, Immunocompromised Host

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review